Abstract
The present study explored neuropeptide responses to nicotine from smoking. Habitual smokers smoked research cigarettes of known strength under controlled laboratory conditions while blood samples were withdrawn unobtrusively for subsequent biochemical analysis. To provide a metric that reflected total nicotine intake and total neurohormonal output, data were integrated over time. Subjects were relatively unresponsive in the low-nicotine (0.48 mg) condition. In the high-nicotine (2.87 mg) condition, there were significant positive correlations between integrated plasma nicotine and plasma arginine vasopressin (r=+0.985), its carrier protein neurophysin I (r=+0.944), and β-endorphin-β-lipotropin (r=+0.977), but not adrenocorticotropic hormone. Data from an experiment that used an extraction step to remove β-lipotropin corroborated the functional relationship between plasma nicotine and β-endorphin implied by the original findings. Taking into account recent research on the role of neuropeptides in the modulation of affective states and cognitive function as well as of other CNS activity, the present findings were interpreted as strengthening the hypothesis that nicotine-stimulated neuropeptide release provides positive reinforcement for smoking.
Similar content being viewed by others
References
Ananth J, Bartova A, Rastogi R (1982) Endorphins and ACTH. In: Shah NS, Donald AG (eds) Endorphins and opiate antagonists in psychiatric research. Plenum, New York, pp 427–437
Andersson K (1975) Effects of cigarette smoking on learning and retention. Psychopharmacologia 41:1–5
Cryer PE, Haymond MW, Santiago JV, Shah SD (1976) Norepinephrine and epinephrine release and adrenergic mediation of smoking: Associated hemodynamic and metabolic events. New Engl J Med 295:573–577
Dax EM, Clappison PT, Pullan R, Pepperell R, Johnson CI (1979) Individual neurophysin concentrations in the pituitary and circulation of humans. Clin Endocrinol 10:253–263
deWied D (1980) Hormonal influences on motivation, learning, memory and psychosis. In: Kreiger D, Hughes JC (eds) Neuroendocrinology. Sinauer, Sunderland MA, pp 194–204
deWied D, Bahus B, van Ree JM, Urban I (1978) Behavioral and electrophysiological effects of peptides related to lipotropin (β-LPH). J Pharmacol Exp Ther 204:570–580
Epstein L, Collins F (1977) The measurement of situational influences of smoking. Addict Behav 2:47–54
Fertig J, Seyler L, Pomerleau O, Hunt D, Parker K (1982) Release of five human pituitary hormones during smoking correlates with nausea and not nicotine (Abstract). Clin Res 30:270
Feyerabend C, Russell M (1978) Effect of urinary pH and nicotine excretion rate on plasma nicotine during cigarette smoking and chewing nicotine gum. Br J Clin Pharmacol 5:293–297
Glick S, Kagon A (1979) Vasopressin. In: Jaffe BM, Behrman H (eds) Methods of hormone radioimmunoassay. Academic, Newark, pp 341–351
Greenwood FC, Hunter WM, Glover JS (1963) The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J 89:114–123
Guillemin R (1978) Peptides in the brain: The new endocrinology of the neuron. Science 202:390–402
Guillemin R, Vargo T, Rossier J, Minich S, Ling N, Rivier C, Vale W, Bloom F (1977) β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197:1367–1370
Henningfield J, Griffiths R (1979) A preparation for the experimental analysis of human cigarette smoking behavior. Behav Res Method Instrument 11:538–544
Hill P, Haley N, Wynder E (1983) Cigarette smoking as a risk for cardiovascular disease. I. Biochemical analyses, carboxyhemoglobin, plasma nicotine, cotinine, and thiocyanate versus self-report smoking data. J Chronic Dis (in press)
Hill P, Wynder E (1974) Smoking and cardiovascular disease: Effect of nicotine on the serum epinephrine and corticoids. Am Heart J 87:491–496
Husain MK, Frantz AC, Ciarochi F, Robinson AG (1975) Nicotine-stimulated release of neurophysin and vasopressin in humans. J Clin Endocrinol Metab 41:1113–1117
Isaac P, Rand M (1972) Cigarette smoking and plasma levels of nicotine. Nature 236:308–310
Jarvik M (1977) Biological factors underlying the smoking habit. Natl Inst Drug Abuse Res Monogr Ser 17:122–148
Jarvik M (1979) Biological influences on cigarette smoking. Natl Inst Drug Abuse Res Monogr Ser 26:7–45
Kalin N, Risch S, Cohen R, Insel T, Murphy D (1980) Dexamethasone fails to suppress β-endorphin plasma concentrations in humans and rhesus monkeys. Science 209:827–828
Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541–1545
Langone J, Gjika H, van Vunakis H (1973) Nicotine and its metabolites: Radioimmunoassay for nicotine and cotinine. Biochemistry 12:5025–5030
LeBoeuf A, Lodge J, Eames PG (1978) Vasopressin and memory in Korsakoff's syndrome. Lancet II:1370–1372
Legros JJ, Gilot P, Seron X, Claessen SJ, Adam A, Moeglen JM, Audibert A, Berchier P (1978) Influence of vasopressin on learning and memory. Lancet I:41–42
Matsukura S, Sakamoto N, Seino Y, Tomade T, Matsuyama H, Muranaka H (1979) Cotinine excretion and daily cigarette smoking in habituated smokers. Clin Pharmacol Ther 25:555–561
Millan M, Emrich H (1981) Endorphinergic systems and the responses to stress. Psychother Psychosom 36:43–56
Miller LH, Kastin AF, Sandman CA, Fink M, van Veen WJ (1974) Polypeptide influences on attention, memory and anxiety in man. Pharmacol Biochem Behav 2:663–668
Pomerleau OF (1981) Underlying mechanisms in substance abuse: Examples from research on smoking. Addict Behav 6:187–196
Pullan PT, Clappison BH, Johnston CI (1979) Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion. J Clin Endocrinol Metab 49:580–587
Rigter H, van Riezen H (1978) Hormones and memory. In: Lipton M, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven, New York, pp 677–689
Robinson A (1975) Isolation, assay, and secretion of individual human neurophysins. J Clin Invest 55:360–367
Rubin R, Warner W (1975) Nicotine-induced stimulation of steroid genesis in adrenocortical cells of the cat. Br J Pharmacol 53:357–362
Russell M (1978) Self-regulation of nicotine intake by smokers. In: Bättig K (ed) Behavioral effects of nicotine. Karger, Basel, pp 108–122
Sannita C, George J, McCarre T, Nolan J, Kaswan J, Kastin A (1977) EEG and task performance after ACTH4–10 in man. Neurophysiobiology 2:283–290
Schachter S (1978) Pharmacological and psychological determinants of smoking. Ann Int Med 88:104–114
Seyler L, Fertig J, Pomerleau O, Hunt D, Parker K (1983) The effects of smoking on ACTH and cortisol secretion. Life Sci (in press)
Siegel S (1979) The role of conditioning in drug tolerance and addiction. In: Keehn J (ed) Psychopathology in animals: Research and clinical applications. Academic, New York, pp 143–168
Silverstein B (1982) Cigarette smoking, nicotine addiction, and relaxation. J Pers Soc Psychol 42:946–950
Texas Instruments Master Library (1977) TI 58/59 Simpson's approximation (discrete). Texas Instruments. Dallas TX, pp 32–34
Turner D (1975) The role of adrenal catecholamines in the release of corticosterone and fatty acids by nicotine in the rat. Res Commun Chem Pathol Pharmacol 12:645–655
van Ree JM, deWied D (1978) Behavioral effects of neuropeptides related to pituitary hormones. In: Fishman J (ed) The bases of addiction. Dahlem Konferenzen, Berlin, pp 221–234
van Ree JM, deWied D (1981) Brain peptides and psychoactive drug effects. In: Israel Y, Glaser F, Kalant H, Popham R, Schmidt W, Smart R (eds) Research advances in alcohol and drug problems, vol 6. Plenum, New York, pp 67–105
van Ree JM, Smyth D, Colpaert F (1979) Dependence-creating properties of lipotropin C-fragment (β-endorphin): Evidence for its internal control of behavior. Life Sci 24:495–502
Weingartner H, Gold P, Ballenger J, Smallberg S, Summers R, Rubinow O, Post R, Goodwin F (1981) Effects of vasopressin on human memory functions. Science 211:601–603
Wesnes K, Warburton D (1978) The effects of cigarette and nicotine tablets upon human attention. In: Thornton R (ed) Smoking behavior. Churchill Livingstone, London, pp 131–147
Wikler A (1965) Conditioning factors in opiate addiction and relapse. In: Wilner D, Kassenbaum G (eds) Narcotics. McGraw Hill, New York, pp 85–100
Wilkes M, Stewart R, Bruni J, Quigley M, Yen S, Ling N, Chrétien M (1980) A specific homologous radioimmunoassay for human β-endorphin: Direct measurement in biological fluids. J Clin Endocrinol Metab 50:309–315
Wilkins J, Carlson H, van Vunakis H, Hill M, Gritz E, Jarvik M (1982) Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 78:305–308
Williams R (ed) (1981) Testbook of endocrinology. Saunders, Philadelphia
Winternitz WW, Quillen D (1977) Acute hormonal responses to cigarette smoking. J Clin Pharmacol 17:389–397
Yamaguchi H, Liotta A, Krieger D (1980) Simultaneous determination of human plasma immunoreactive β-lipotropin, γ-lipotropin and β-endorphin using immune-affinity chromatography. J Clin Endocrinol Metab 51:1002–1008
Author information
Authors and Affiliations
Additional information
Offprint requests to: Bld. 5, Research V.A. Medical Center, Newington, CT 06111, USA
Rights and permissions
About this article
Cite this article
Pomerleau, O.F., Fertig, J.B., Seyler, L.E. et al. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81, 61–67 (1983). https://doi.org/10.1007/BF00439275
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00439275